A study to evaluate the effectiveness of vidanga(Embelia ribes) powder in the management of Gastritis caused by infection (Helicobacter pylori)

Clinical study to evaluate the efficacy of vidanga churna in the management of Urdhwaga Amlapitta due to Helicobacter pylori.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/053006

Enrollment

Registered

2023-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K296- Other gastritis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Symptoms- 1.Sour or bitter eructation/belching 2.nausea, pyrosis, water brash, 3.Indigestion,Loss of appetite 4.Gaseous distension, heaviness of body 5.Positive Helicobacter pylori in upper GI endoscopy yr

Exclusion criteria

Exclusion criteria: 1.Any Cancer of Gastrointestinal tract 2.Past history of Abdominal surgery 3.Pregnant and lactating mother 4.Patients of major systemic illness including Cardiac, hepatobiliary, kidney and IBS 5.Hiatus hernia 6.Major Oral pharyngeal and laryngeal infections

Design outcomes

Primary

Measure	Time frame
1.To Decrease the symptoms of pyrosis,nausea,sour eructation, bloating, abdominal pain 2.To improve digestion and appetiteTimepoint: 60 days	—

Secondary

Measure	Time frame
Upper Gastrointestinal Endoscopy with negative H.pylori(RUT)Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Ranjan kalita

Government Ayurvedic college and Hospital GHY 14

maniziiakayina56@gmail.com7085712596

Outcome results